Protalix Biotherapeutics, Inc. (PLX)
2.375
+0.02
(+0.64%)
USD |
NYAM |
Apr 15, 16:00
2.375
0.00 (0.00%)
After-Hours: 20:00
Protalix Biotherapeutics Research and Development Expense (Annual) : 19.05M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Agenus, Inc. | 79.34M |
| Lisata Therapeutics, Inc. | 7.949M |
| InspireMD, Inc. | 15.00M |
| Lifeward Ltd. | 3.249M |
| Denali Therapeutics, Inc. | 418.78M |